IL103684A0 - Novel hybrid transforming growth factors - Google Patents

Novel hybrid transforming growth factors

Info

Publication number
IL103684A0
IL103684A0 IL103684A IL10368492A IL103684A0 IL 103684 A0 IL103684 A0 IL 103684A0 IL 103684 A IL103684 A IL 103684A IL 10368492 A IL10368492 A IL 10368492A IL 103684 A0 IL103684 A0 IL 103684A0
Authority
IL
Israel
Prior art keywords
growth factors
transforming growth
novel hybrid
hybrid transforming
novel
Prior art date
Application number
IL103684A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL103684A0 publication Critical patent/IL103684A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL103684A 1991-11-11 1992-11-08 Novel hybrid transforming growth factors IL103684A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91810870 1991-11-11

Publications (1)

Publication Number Publication Date
IL103684A0 true IL103684A0 (en) 1993-04-04

Family

ID=8208899

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103684A IL103684A0 (en) 1991-11-11 1992-11-08 Novel hybrid transforming growth factors

Country Status (12)

Country Link
EP (1) EP0542679A1 (ref)
JP (1) JPH05306297A (ref)
KR (1) KR930010177A (ref)
AU (1) AU2738392A (ref)
CA (1) CA2082450A1 (ref)
FI (1) FI925086A7 (ref)
IL (1) IL103684A0 (ref)
MX (1) MX9206456A (ref)
NO (1) NO924323L (ref)
NZ (1) NZ245047A (ref)
TW (1) TW240231B (ref)
ZA (1) ZA928647B (ref)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5436228A (en) * 1990-12-12 1995-07-25 Postlethwaite; Arnold E. Chemotactic wound healing peptides
US5824647A (en) * 1990-12-12 1998-10-20 Postlethwaite; Arnold E. Chemotactic wound healing peptides
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
DE69435137D1 (de) * 1993-05-13 2008-10-16 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
TW517059B (en) * 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
TW440566B (en) * 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein
EP0833624B1 (en) 1995-06-07 2007-11-07 Poniard Pharmaceuticals, Inc. Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
AU6959898A (en) 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
ES2226414T3 (es) 1998-06-10 2005-03-16 Biognostik Gesellschaft Fur Biomolekulare Diagnostik Mbh Estimulacion del sistema inmunitario.
WO2002012336A2 (en) * 2000-08-09 2002-02-14 Curis, Inc. TGF-β THERAPEUTICS, COMPOSITIONS AND METHODS OF USE
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US20060019916A1 (en) * 2004-04-02 2006-01-26 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for inducing IL-10 responses
US9758786B2 (en) 2016-02-09 2017-09-12 Autotelic, Llc Compositions and methods for treating pancreatic cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
CA2005120A1 (en) * 1988-12-15 1990-06-15 Anthony F. Purchio Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta

Also Published As

Publication number Publication date
TW240231B (ref) 1995-02-11
MX9206456A (es) 1993-07-01
NZ245047A (en) 1995-04-27
FI925086A0 (fi) 1992-11-09
NO924323L (no) 1993-05-12
FI925086L (fi) 1993-05-12
NO924323D0 (no) 1992-11-10
CA2082450A1 (en) 1993-05-12
ZA928647B (en) 1993-06-21
EP0542679A1 (en) 1993-05-19
KR930010177A (ko) 1993-06-22
FI925086A7 (fi) 1993-05-12
AU2738392A (en) 1993-05-13
JPH05306297A (ja) 1993-11-19

Similar Documents

Publication Publication Date Title
EP0503050A4 (en) Hybrid growth factors
IL103684A0 (en) Novel hybrid transforming growth factors
AU1398792A (en) Hybrid polypeptide
EP0728142A4 (en) INNOVATIVE, ANTIQUE BONE GROWTH FACTOR
AU6802198A (en) Immunostimulating swainsoinine analogs
AU1340688A (en) Transforming growth factor-beta
GB2269732B (en) Growing system
AU1176492A (en) Device for accelerating growth
GB9225928D0 (en) Growth factor
AU1353692A (en) Equine epidermal growth factor
GB9208488D0 (en) Novel transforming growth factor fragments
AU299P (en) TENNESSEE Rosa hybrid
GB9102890D0 (en) Hybrid seed production
AU404P (en) LAVJACK Rosa hybrid
AU384P (en) MEIFLOPAN Rosa hybrid
AU385P (en) MEINEBLE Rosa hybrid
AU194P (en) TANFUDERMOS Rosa hybrid
AU324P (en) Auswhite Rosa hybrid
AU316P (en) KORSORB Rosa hybrid
AU305P (en) SELTITAAN Rosa hybrid
AU279P (en) MEIZOGREL Rosa hybrid
AU280P (en) MEISELGRA Rosa hybrid
AU293P (en) MEIGRONURISAR Rosa hybrid
AU294P (en) MEIPLATIN Rosa hybrid
AU297P (en) KORFERSE Rosa hybrid